​

Beta Bionics (BBNX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BBNX Stock Forecast

Beta Bionics (BBNX) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $30.00, with a high of $40.00 and a low of $17.00. This represents a 102.98% increase from the last price of $14.78.

BBNX Stock Rating

Beta Bionics stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

BBNX Price Target Upside V Benchmarks

TypeNameUpside
StockBeta Bionics102.98%
SectorHealthcare Stocks 15.45%

Price Target Trends

1M3M12M
# Anlaysts3513
Avg Price Target$27.33$29.40$28.92
Last Closing Price$14.78$14.78$14.78
Upside/Downside84.91%98.92%95.67%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26181--10
Dec, 25181--10
Nov, 25181--10
Oct, 25171--9
Sep, 25162--9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 26, 2026Cowen & Co.$17.00$15.469.96%15.02%
Jan 15, 2026David RomanGoldman Sachs$25.00$16.9947.15%69.15%
Jan 09, 2026Lake Street$40.00$21.2688.15%170.64%
Dec 18, 2025Richard NewitterTruist Financial$37.00$30.4521.51%150.34%
Dec 16, 2025Robert W. Baird$28.00$29.73-5.82%89.45%
Oct 29, 2025Frank TakkinenLake Street$35.00$24.2844.15%136.81%
Oct 29, 2025Jonathan BlockStifel Nicolaus$31.00$24.2827.68%109.74%
Oct 29, 2025David RomanGoldman Sachs$33.00$24.2835.91%123.27%
Oct 29, 2025Robert W. Baird$23.00$24.28-5.27%55.62%
Oct 29, 2025Matt O'BrienPiper Sandler$32.00$28.3212.99%116.51%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 26, 2026Cowen & Co.Holdinitialise
Jan 15, 2026Goldman SachsBuyBuyhold
Jan 09, 2026Lake StreetBuyBuyhold
Oct 29, 2025Lake StreetBuyBuyhold
Oct 29, 2025Goldman SachsBuyBuyhold
Oct 29, 2025Piper SandlerOverweightOverweighthold
Oct 01, 2025Goldman SachsBuyupgrade

Financial Forecast

EPS Forecast

$-9 $-8 $-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-8.60-----
Avg Forecast$-2.13$-1.84$-1.96$-2.03$-1.61$-0.95
High Forecast$-1.74$-1.37$-1.52$-0.65$-1.53$-0.90
Low Forecast$-2.75$-2.04$-2.20$-2.72$-1.68$-0.99
Surprise %303.76%-----

Revenue Forecast

$50M $100M $150M $200M $250M $300M Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$65.12M-----
Avg Forecast$64.87M$82.68M$111.56M$150.21M$206.79M$270.39M
High Forecast$65.20M$84.80M$116.46M$150.21M$214.26M$280.16M
Low Forecast$63.79M$80.70M$106.20M$150.21M$198.97M$260.17M
Surprise %0.39%-----

Net Income Forecast

$-55M $-44M $-33M $-22M $-11M $0 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-54.76M-----
Avg Forecast$-14.28M$-10.83M$-11.85M$-10.73M$-10.22M$-6.05M
High Forecast$-11.05M$-8.71M$-9.70M$-4.11M$-9.71M$-5.75M
Low Forecast$-17.51M$-12.96M$-13.99M$-17.34M$-10.70M$-6.33M
Surprise %283.51%-----

BBNX Forecast FAQ

Is Beta Bionics stock a buy?

Beta Bionics stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Beta Bionics is a favorable investment for most analysts.

What is Beta Bionics's price target?

Beta Bionics's price target, set by 7 Wall Street analysts, averages $30 over the next 12 months. The price target range spans from $17 at the low end to $40 at the high end, suggesting a potential 102.98% change from the previous closing price of $14.78.

How does Beta Bionics stock forecast compare to its benchmarks?

Beta Bionics's stock forecast shows a 102.98% upside, outperforming the average forecast for the healthcare stocks sector (15.45%).

What is the breakdown of analyst ratings for Beta Bionics over the past three months?

  • January 2026: 10.00% Strong Buy, 80.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 10.00% Strong Buy, 80.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 10.00% Strong Buy, 80.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.

What is Beta Bionics’s EPS forecast?

Beta Bionics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.84, marking a -78.60% decrease from the reported $-8.6 in 2024. Estimates for the following years are $-1.96 in 2026, $-2.03 in 2027, $-1.61 in 2028, and $-0.95 in 2029.

What is Beta Bionics’s revenue forecast?

Beta Bionics's average annual revenue forecast for its fiscal year ending in December 2025 is $82.68M, reflecting a 26.96% increase from the reported $65.12M in 2024. The forecast for 2026 is $111.56M, followed by $150.21M for 2027, $206.79M for 2028, and $270.39M for 2029.

What is Beta Bionics’s net income forecast?

Beta Bionics's net income forecast for the fiscal year ending in December 2025 stands at $-10.833M, representing a -80.22% decrease from the reported $-54.756M in 2024. Projections indicate $-11.846M in 2026, $-10.726M in 2027, $-10.216M in 2028, and $-6.047M in 2029.